Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Perfusion ; 32(3): 214-219, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27789847

ABSTRACT

BACKGROUND: Since the introduction of CO2 insufflation during open heart surgery in our hospital, we incidentally observed thrombus formation in the dissected heart, in the pericardium and in the cardiotomy reservoir of the cardiopulmonary bypass system. Furthermore, we measured very high levels of pCO2, causing severe acidosis, in stagnant blood in the pericardium and cardiotomy reservoir. OBJECTIVES: In this in vitro study, we assessed the influence of acidosis and hypothermia on heparin potency and thrombin formation. METHODS: We assessed heparin potency in function of pH (pH 5.0-7.4) and temperature (24-37°C) by comparing the activated partial thromboplastin time in platelet-poor plasma between samples with and without unfractionated heparin. We measured thrombin formation in platelet-poor plasma by means of fluorescent, calibrated, automated thrombography in function of pH (pH 5.0-7.4) and temperature (24-37°C). The parameters of interest were the endogenous thrombin potential and the peak amount of thrombin generation. RESULTS: The major finding of this study is the significant decrease in the efficiency of unfractionated heparin in delaying thrombus formation at acidotic (pH 5.0-7.0) conditions (p=0.034-0.05). Furthermore, we found that thrombin formation is significantly increased at hypothermic (24-34°C) conditions (p=<0.001-0.01). CONCLUSIONS: Based on the results of our in-vitro study, we conclude that acidosis may lead to a decreased heparin potency. Acidosis, as induced by CO2 insufflation, may predispose patients to incidental thrombus formation in stagnant blood in the open thorax and in the cardiotomy reservoir. Hypothermia might further increase this risk. Therefore, we recommend reconsidering the potential advantages and disadvantages of using CO2 insufflation during cardiopulmonary bypass.


Subject(s)
Acidosis/blood , Anticoagulants/pharmacology , Blood Coagulation/drug effects , Carbon Dioxide/blood , Heparin/pharmacology , Insufflation/adverse effects , Thrombosis/etiology , Acidosis/etiology , Anticoagulants/therapeutic use , Blood Coagulation Tests , Blood Gas Analysis , Heparin/therapeutic use , Humans , Hypothermia, Induced/adverse effects , Hypothermia, Induced/methods , Insufflation/methods , Risk Factors , Thrombosis/blood , Thrombosis/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...